Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial. Dummer Reinhard et al. The Lancet. Oncology 2018 19(10) 1315-1327

Main|Search|PHGKB

Last Posted: Jun-24-2019 11AM

Last Posted: Jun 24, 2019

---

• Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial.
  Dummer Reinhard et al. The Lancet. Oncology 2018 19(10) 1315-1327
• Proteomic investigations into hypertension: what's new and how might it affect clinical practice?
  Corbacho-Alonso N et al. Expert review of proteomics 2019 Jun
• Computer-Aided Diagnosis and Clinical Trials of Cardiovascular Diseases Based on Artificial Intelligence Technologies for Risk-Early Warning Model.
  Li Bin et al. Journal of medical systems 2019 Jun 43(7) 228
• The CADASIL Scale-J, A Modified Scale to Prioritize Access to Genetic Testing for Japanese CADASIL-Suspected Patients.
  Koizumi Takashi et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2019 Jun 28(6) 1431-1439
• Evaluating Reach, Acceptability, Utility, and Engagement with An App-Based Intervention to Improve Medication Adherence in Patients with Coronary Heart Disease in the MedApp-CHD Study: A Mixed-Methods Evaluation.
  Santo Karla et al. Medical sciences (Basel, Switzerland) 2019 Jun 7(6)
• What matters the adherence with BP 24-hr self-monitoring wearable device among hypertensive patients? A population-based survey.
  Zhang Yuting et al. Translational behavioral medicine 2019 Jun
• Comparison of long-term outcomes of young patients after a coronary event associated with familial hypercholesterolemia.
  Wang Xu et al. Lipids in health and disease 2019 Jun 18(1) 131
• Smartphone Apps to Support Self-Management of Hypertension: Review and Content Analysis.
  Alessa Tourkiah et al. JMIR mHealth and uHealth 2019 May 7(5) e13645
• The importance and challenges of developing a pharmacogenetics test for hypertension.
  Snyder Eric M et al. Pharmacogenomics 2019 May
• The preimplantation genetic testing debate continues: first the hype, then the tension, now the hypertension?
  Patounakis George et al. Fertility and sterility 2019 May

more